Monster Beverage to Report Financial Results for 2024 Second Quarter on August 7, 2024
July 31, 2024 08:00 ET
|
Monster Beverage Corporation
-- Company to Conduct Conference Call at 2 p.m. Pacific Time -- CORONA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) announced today that results for its...
Immutep Quarterly Activities Report Q4 FY24
July 31, 2024 08:00 ET
|
Immutep Limited
Media Release Entered into third and most important clinical trial collaboration and supply agreement to date with MSD to evaluate eftilagimod alfa (efti) in combination with KEYTRUDA®...
KnowBe4 Maintains G2 Leadership Streak in Summer 2024 Report, Topping Both Security Awareness and SOAR Categories
July 31, 2024 08:00 ET
|
KnowBe4, Inc.
TAMPA BAY, FL, July 31, 2024 (GLOBE NEWSWIRE) -- KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today announced its continued top ranking...
authID Inc. Partners with Kaiasoft.com to Elevate Best-In-Class SaaS Applications with Biometric Identity Assurance
July 31, 2024 08:00 ET
|
authID Inc.
authID to stop malicious, generative AI-driven cyberattacks and deepfakes for Kaiasoft.com SaaS clients across America and Europe DENVER, July 31, 2024 (GLOBE NEWSWIRE) -- authID.ai [Nasdaq:...
Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™
July 31, 2024 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Fibromyalgia is a “diagnosable condition” in people suffering from Long COVID according to NASEM1 Diagnosing fibromyalgia in Long COVID patients is expected to expand the potential...
Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
July 31, 2024 08:00 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision...
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
July 31, 2024 08:00 ET
|
Envoy Medical, Inc
Envoy Medical’s FDA-Approved Esteem® Fully Implanted Active Middle Ear Hearing Device May Now Have an Opportunity to be a Coverable Benefit WHITE BEAR LAKE, Minnesota, July 31, 2024 (GLOBE...
CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024
July 31, 2024 08:00 ET
|
CareCloud, Inc
SOMERSET, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems...
TTM Technologies, Inc. Reports Second Quarter 2024 Results
July 31, 2024 08:00 ET
|
TTM Technologies, Inc.
SANTA ANA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”)...
IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
July 31, 2024 08:00 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that it...